Skip to main content
Livermore
Livermore
ZHEN

Dodge & Cox

SEC CIK
0000200217
Latest filing
Aug 13, 2026

NVS holding history

Novartis AG in every 13F filed by Dodge & Cox, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVS overviewAll 13F holders of NVSFull Q2 2026 holdings

Shares (Q2 2026)
759,373
Value
$119.0M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of NVS by Dodge & Cox, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026759,373$119.0M0.1%−6,208,010−89.1%ReducedHolders
Q1 20266,967,383$1.06B0.6%−2,047,258−22.7%ReducedHolders
Q4 20259,014,641$1.24B0.7%−1,570,504−14.8%ReducedHolders
Q3 202510,585,145$1.36B0.7%−62,484−0.6%ReducedHolders
Q2 202510,647,629$1.29B0.7%−1,170,473−9.9%ReducedHolders
Q1 202511,818,102$1.32B0.8%−396,563−3.2%ReducedHolders
Q4 202412,214,665$1.19B0.7%−7,211−0.1%ReducedHolders
Q3 202412,221,876$1.41B0.8%−14,650−0.1%ReducedHolders
Q2 202412,236,526$1.30B0.8%−117,459−1.0%ReducedHolders
Q1 202412,353,985$1.20B0.7%−811,553−6.2%ReducedHolders
Q4 202313,165,538$1.33B0.8%−3,098,683−19.1%ReducedHolders
Q3 202316,264,221$1.66B1.1%−142,892−0.9%ReducedHolders
Q2 202316,407,113$1.66B1.1%−3,905,567−19.2%ReducedHolders
Q1 202320,312,680$1.87B1.3%−438,692−2.1%ReducedHolders
Q4 202220,751,372$1.88B1.3%−297,285−1.4%ReducedHolders
Q3 202221,048,657$1.60B1.2%−1,504,112−6.7%ReducedHolders
Q2 202222,552,769$1.91B1.3%−5,291,440−19.0%ReducedHolders
Q1 202227,844,209$2.44B1.5%−405,331−1.4%ReducedHolders
Q4 202128,249,540$2.47B1.5%−1,016,360−3.5%ReducedHolders
Q3 202129,265,900$2.39B1.6%+4,812,635+19.7%AddedHolders
Q2 202124,453,265$2.23B1.5%+2,783,028+12.8%AddedHolders
Q1 202121,670,237$1.85B1.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.